RA Capital Management, L.P. 13D/13G Filings for Prelude Therapeutics Incorporated (PRLD)

RA Capital Management, L.P. 13D and 13G filings for Prelude Therapeutics Incorporated:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-04-28
5:16 pm
Purchase
2026-04-2113GPRELUDE THERAPEUTICS INC
PRLD
RA Capital Management, L.P.6,477,309
9.900%
6,477,309increase
(New Position)
Filing